BiotechTube
Home/Investors/Public Shareholders (HKEX)

Public Shareholders (HKEX)

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$4.9B
Focus Areas
6
Top Stage
commercial

Investment Focus

CardiovascularNeurologyOncologyFibrotic DiseasesCardiovascular & Metabolic DiseasesMedical Aesthetics

Portfolio Companies

CompanyValuation
Peijia Medical$4.2B
Sirnaomics$712.2M